The Effects of Caffeine and L-theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood

Northumbria University

Status and phase: Completed; Phase 4

Conditions: Cognitive Function; Mood

Treatments: Dietary Supplement: Caffeine and L-theanine

Study type: Interventional

Funder types: Other

Identifiers

NCT00981955

25AA1

Details and patient eligibility

About

Although the beneficial effects of caffeine on cognition and mood have been reported in a number of studies, relatively few studies have looked at the effects of caffeine in combination with other phytonutrients despite the fact that caffeine is seldom consumed in isolation. L-theanine is a naturally occurring amino-acid found in tea, and has been used historically as a relaxing agent (Haskell et al., 2008). Few have assessed the impact of l-theanine on cognition, but of those that have, the most interesting results were obtained when l-theanine was assessed in combination with caffeine (Haskell et al., 2008). It remains unclear what is underlying the reported effects.

Near Infrared Spectroscopy (NIRS) is an emerging neuroimaging technology that is capable of determining changes in cerebral blood flow (CBF) by measuring the optical properties of oxygenated and deoxygenated blood (Bunce et al., 2006). No study to date has used NIRS to assess cerebral blood flow following treatment with either caffeine, l-theanine or a combination of both. It is anticipated that the proposed study will provide some insight into the mechanism of the previously observed effects both alone and in combination.

A randomised, double-blind, placebo controlled, balanced crossover design study will assess the effects of 75mg caffeine, 50mg l-theanine and a 75mg caffeine/50mg l-theanine combination in 24 young healthy adults (18-35). Cognitive and mood assessments will take place at baseline and at 30 minutes following treatment whilst cerebral haemodynamics are measured via the technique of NIRS.

Enrollment: 24 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy
• Aged 18-35
• Either caffeine consumers (consume more than 150mg caffeine per day) or non-consumers (less than 44mg caffeine per day).

Exclusion criteria

• Smoke or consume any tobacco products
• Not proficient in English language
• Pregnant (or seeking to become pregnant)
• Taking recreational, over the counter/prescription medication (including the contraceptive pill), and/or dietary/herbal supplements
• Have food allergies or sensitivities
• Have history of/current head trauma, learning difficulties , ADHD, migraines or any gastric problems

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Triple Blind

---

24 participants in 4 patient groups, including a placebo group

75mg caffeine

Active Comparator group

Treatment:

Dietary Supplement: Caffeine and L-theanine

50mg l-theanine

Active Comparator group

Treatment:

Dietary Supplement: Caffeine and L-theanine

75mg caffeine and 50mg l-theanine

Active Comparator group

Treatment:

Dietary Supplement: Caffeine and L-theanine

0mg caffeine/l-theanine

Placebo Comparator group

Treatment:

Dietary Supplement: Caffeine and L-theanine